Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation

Part of paid clinical trials in Orange, California.

Sponsor
University of California, Irvine
Study ID
NCT07568756
Phase
PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Flotufolastat F18 PET — DIAGNOSTIC_TEST
    Flotufolastat F18 PET

Study Details

This is a phase II single arm, open-label clinical trial determining diagnostic accuracy of Flotufolastat F18 PET in subjects with prostate adenocarcinoma. These are subjects who have not previously received treatment for prostate cancer.

Key Dates

Start date
May 31, 2026
Status verified
Apr 2026
Primary completion
May 31, 2028
Completion
May 31, 2029

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Post-Focal Therapy Flotufolastat F18PET
    Post-Focal Therapy Flotufolastat F18 PET

Primary Outcome Measure

Flotufolastat F18 PET findings [ Time Frame: 5 years ]

Central Contacts

  • Chao Family Comprehensive Cancer Center University of California, Irvine
    1-877-827-8839
    [email protected]
  • University of California Irvine Medical Center

Locations (1)

FacilityCityStateZIPSite coordinators
Chao Family Comprehensive Cancer Center, University of California, IrvineOrangeCalifornia92868
Michael Daneshvar, MD
[email protected]
877-827-8839

Find similar trials in Orange, CA

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
Chao Family Comprehensive Cancer Center, University of California, Irvine· Orange, CA

Related Studies